Ensuring accuracy in the development and application of nucleic acid amplification tests (NAATs) for infectious disease

News - During COVID-19, bioanalytical diagnostic techniques (like PCR and lateral flow tests) were widely discussed across the world. This paper discusses learnings from the COVID-19 pandemic and offers alternative approaches to conventional diagnostic evaluations for infectious disease to improve diagnostic performance assessment and meet increased regulatory requirements.

21 June 2024